Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05174455
Title Niraparib for the Treatment of Leiomyosarcoma
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ohio State University Comprehensive Cancer Center
Indications

leiomyosarcoma

Therapies

Niraparib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.